Category Archives: biotechnology

CMS Meaningful Use Payments to Providers: Incentives or Sophie’s Choice?

Sophie’s Choice: You have to choose when there are no good options. Sophie’s Choice was an award-winning 1983 movie based on the William Styron novel about a Nazi concentration camp survivor who was forced to choose which of her two children to send … Continue reading

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health IT, health policy, health reform | Leave a comment

Healthcare Visionaries Lead the Way

Technology is moving much faster than the snail’s pace of government and regulation. It is an exciting time to be – not just in healthcare – but to be alive. I’ve been hanging around the virtual water cooler in healthcare … Continue reading

Posted in biotechnology, consumer health apps, elearning, electronic patient records, health economics, health insurance, health IT, health IT training, health policy, health reform | Leave a comment

Health Wonk Review: Groundhog Zombie Goes Back to the Future

With a title like that, who is strong enough to resist clicking on this link to read more? I challenge the most susceptible among you to ignore this post! Julie Ferguson at Workers’ Comp Insider is our creative mistress of ceremonies … Continue reading

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health insurance, health IT, health policy, health reform, healthcare marketing | Leave a comment

The “May You Live in Interesting Times” Edition of Health Wonk Review

Just when you thought things can’t get any weirder, they do. Combine staunch opposed ideologies held by fierce political warriors, and we find ourselves under the ancient curse of living in interesting times. It seems our nation is transitioning from … Continue reading

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health insurance, health IT, health policy, health reform, pharmaceutical marketing | 6 Comments

The President’s Day Edition of Health Wonk Review on Your Virtual Newsstand Now

David E. Williams is on top of the President’s Day Edition of Health Wonk Review. Click here to go to David’s Health Business Group blog for this special edition on your virtual newsstand today. I also want to add my … Continue reading

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health insurance, health IT, health policy, health reform, healthcare marketing, pharmaceutical marketing | Leave a comment

Fresh Prints: An All-New, Alt-Fax Edition of Health Wonk Review

Health Wonk Review for February 9, 2017 #alternative_facts Edition By Steve Anderson medicareresources.org Editor February 9, 2017 Honesty is such a lonely word. Everyone is so untrue. – Billy Joel The title of Billy Joel’s hit song wouldn’t have been nearly … Continue reading

Posted in biotechnology, consumer health apps, elearning, electronic patient records, health economics, health insurance, health IT, health policy, health reform | Leave a comment

Healthcare’s Future? Population Health and Information Technology

Many people are wondering if we are living in a post-ACA world. The uncertainty has pundits posturing all over the political map. No matter how the economy or politics turn, there are a few constants where people can have some … Continue reading

Posted in biotechnology, electronic patient records, health economics, health insurance, health IT, health policy, health reform, healthcare marketing | Leave a comment

Puppies and Kittens Edition of Health Wonk Review

Hank Stern’s roundup of wonkery and punditry as the Health Wonk Review group looks at where things are going under a new administration in DC in this Puppies and Kittens edition of our beloved HWR. Here come da fuzz.

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health insurance, health IT, health policy, health reform, Uncategorized | Leave a comment

Healthcare Industry in an Age of Uncertainty

Uncertainty.  The markets hate it. Established, successful businesses hate it. The markets are priced using certain assumptions, and successful businesses usually got that way under the current rules. So any disruption is a cause to pause. During that pause, some … Continue reading

Posted in biotechnology, electronic patient records, health economics, health insurance, health IT, health policy | Leave a comment

A Post-Election Report from Pennsylvania: The ACA Factor?

The federal government promised health insurance companies that they’d be made whole by the feds if they had shortfalls while participating in ACA marketplaces. Many insurance companies have since found out all their money is not promptly forthcoming and their … Continue reading

Posted in biotechnology, electronic patient records, health economics, health insurance, health IT, health policy, health reform | 1 Comment